Live Ventures (LIVE) had the highest return in January 2014 by a US stock with a market cap of $50M+, returning 369.2%.

ASSET	MONTH	% RETURN
Live Ventures (LIVE)	January 2014	369.21%
Capricor Therapeutics (CAPR)	January 2014	319.25%
Harrow Health (HROW)	January 2014	151.82%
Opus Genetics (IRD)	January 2014	125.49%
Cytosorbents Crp (CTSO)	January 2014	118.75%
Anixa Biosciences (ANIX)	January 2014	103.54%
Heritage Global (HGBL)	January 2014	93.55%
Digimarc (DMRC)	January 2014	91.12%
Savara (SVRA)	January 2014	86.91%
Neurocrine Biosciences (NBIX)	January 2014	84.36%
CorMedix (CRMD)	January 2014	83.06%
Lightbridge (LTBR)	January 2014	81.63%
CEL-SCI (CVM)	January 2014	79.66%
Siebert Financial (SIEB)	January 2014	76.05%
Arbutus Biopharma (ABUS)	January 2014	75.6%
Galectin Therapeutics (GALT)	January 2014	71.16%
Identiv (INVE)	January 2014	71.15%
Alterity Therapeutics (ATHE)	January 2014	65.95%
NioCorp Developments Ltd Common Stock (NB)	January 2014	64.29%
Lantronix (LTRX)	January 2014	61.28%
Intellinetics (INLX)	January 2014	60%
Digital Turbine (APPS)	January 2014	57.95%
PTC Therapeutics (PTCT)	January 2014	55.83%
Abeona Therapeutics (ABEO)	January 2014	53.15%
TG Therapeutics (TGTX)	January 2014	51.52%